Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Reata Pharmaceuticals (RETA) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 16 quarters since 2017. Compare with RETA stock chart to see long term trends.

RETA stock compared to

RETA Income Statement

Revenue, Net:3192000
Revenue Per Share:0.09
Research & Development Expense:37461000
Total Operating Expenses:57173000
Operating Income:-65927000
Income Taxes:-151000
Net Income:-65776000
Earnings Per Share, Basic:-1.91
Shares Outstanding, Basic Avg:33709480

RETA Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-45140000
Net Cash from Financing Activities:285415000
Property, Plant & Equipment Purchases:388000
Net Cash from Investing Activities:-388000
Net Change in Cash & Equivalents:239887000

RETA Balance Sheet

Cash and Cash Equivalents:818150000
Total Current Assets:847338000
Property, Plant & Equipment, Net:4912000
Total Assets:857598000
Accounts Payable:4790000
Total Short-Term Liabilities:119202000
Long Term Debt, Non-Current Portion:0

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Wellington Management Group Llp
3,989,752 sh
248,053 sh
7%
$388,681
-$195,099
Vanguard Group Inc
2,114,097 sh
-89,454 sh
-4%
$205,956
-$137,842
Blackrock Inc.
1,376,084 sh
-230,646 sh
-14%
$134,058
-$116,623
Price T Rowe Associates Inc /Md/
919,926 sh
-9,396 sh
-1%
$89,619
-$55,374
Invesco Ltd.
562,631 sh
509,453 sh
958%
$54,812
$46,515
Duquesne Family Office LLC
543,901 sh
11,023 sh
2%
$52,987
-$30,153
FMR LLC
492,416 sh
-374,432 sh
-43%
$47,971
-$87,275
Deerfield Management Company, L.P. (Series C)
448,000 sh
186,235 sh
71%
$43,644
$2,803
Deerfield Management Company, L.P. (Series C)
448,000 sh
186,235 sh
71%
$43,644
$2,803
Goldman Sachs Group Inc
309,610 sh
29,121 sh
10%
$30,162
-$13,599
Paragon Associates & Paragon Associates Ii Joint Venture
150,000 sh
-51,000 sh
-25%
$14,613
-$16,747
Amundi Pioneer Asset Management Inc
124,834 sh
-3,584 sh
-3%
$12,161
-$7,875
Northern Trust Corp
120,462 sh
-9,412 sh
-7%
$11,735
-$8,528
Keel Point, LLC
120,261 sh
3,114 sh
3%
$11,716
-$6,561
Charles Schwab Investment Management Inc
118,386 sh
-12,285 sh
-9%
$11,534
-$8,854
Voya Investment Management LLC
83,551 sh
31,405 sh
60%
$8,139
$3
Kennedy Capital Management, Inc.
72,792 sh
-656 sh
-1%
$7,091
-$4,368
Bank Of America Corp /De/
61,353 sh
-2,699 sh
-4%
$5,977
-$4,018
Ameriprise Financial Inc
60,475 sh
-180,393 sh
-75%
$5,892
-$31,688
California State Teachers Retirement System
42,284 sh
1,577 sh
4%
$4,119
-$2,232

Data imported from Reata Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.